Skip to main content
BIIB logo
BIIB
(NASDAQ)
Biogen Inc.
$215.43-- (--)
Loading... - Market loading

Biogen Inc. (BIIB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Biogen Inc. stock.

Analyst Consensus Rating

Investment consensus from 34 professional research analysts

Consensus Rating

Buy
Based on 34 unique analysts
(47 total ratings in last 90 days)
Very High Confidence7.0:1 Buy/Sell

Average Price Target

$229.08
6.34% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BIIB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kinjel Shah
Zacks Equity Research
HoldInitiates Coverage
-
UK
Investing.com
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$245.00 $248.00
Andrew Fein
HC Wainwright
BuyReiterates
$237.00 $251.00
Phil Nadeau
TD Cowen
BuyInitiates Coverage
$215.00 $225.00
Evan Seigerman
BMO Capital
HoldReiterates
$196.00 $208.00
Chris Schott
JP Morgan
HoldMaintains
$185.00 $210.00
Michael Yee
UBS
BuyMaintains
$225.00 $240.00
Mohit Bansal
Wells Fargo
BuyMaintains
$250.00
Terence Flynn
Morgan Stanley
HoldMaintains
$222.00 $231.00
Google Drug Manufacturers - General
TipRanks - Google
BuyReiterates
$225.00 $231.00
PerPlexity Drug Manufacturers - General
TipRanks - PerPlexity
BuyReiterates
$228.00 $234.00
Anthropic Drug Manufacturers - General
TipRanks - Anthropic
HoldReiterates
$204.00 $212.00
DeepSeek Drug Manufacturers - General
TipRanks - DeepSeek
BuyReiterates
$221.00 $236.00
xAi Drug Manufacturers - General
TipRanks - xAI
BuyDowngrades
$226.00
OpenAI Drug Manufacturers - General
TipRanks - OpenAI
BuyReiterates
$222.00 $226.00
Myles Minter
William Blair
BuyMaintains
-
Jason Zemansky
BofA Securities
HoldReiterates
$215.00 $219.00
Ami Fadia
Needham
BuyMaintains
$256.00
Deepanwita Sarkar Saha
Zacks Equity Research
BuyInitiates Coverage
-
Yatin Suneja
Guggenheim
BuyInitiates Coverage
$260.00 $280.00
Sundeep Ganoria
Zacks Equity Research
SellInitiates Coverage
-
Sumant Kulkarni
Canaccord Genuity
BuyReiterates
$245.00
David Amsellem
Piper Sandler
BuyReiterates
$225.00
Thomas Shrader
BTIG
HoldMaintains
-
Salveen Richter
Goldman Sachs
BuyMaintains
$250.00
Geoff Meacham
Citi
HoldMaintains
$200.00
Zacks Equity Research
Zacks Equity Research
SellInitiates Coverage
-
Laura Chico
Wedbush
HoldReiterates
$196.00 $201.00
Thomas Shrader
BTIG
HoldMaintains
-
Andrew Tsai
Jefferies
BuyMaintains
$255.00
Salveen Richter
Goldman Sachs
BuyMaintains
$250.00
Evan Seigerman
BMO Capital
HoldMaintains
$196.00
Jasper Hellweg
Argus Research
HoldMaintains
-
Jason Zemansky
BofA Securities
HoldReiterates
$203.00 $217.00
Terence Flynn
Morgan Stanley
HoldMaintains
$224.00 $222.00
Andrew Tsai
Jefferies
BuyMaintains
$255.00
Brian Abrahams
RBC Capital
BuyMaintains
$227.00 $242.00
Morten Herholdt
HSBC
SellMaintains
$150.00 $157.00
Ananda Ghosh
HC Wainwright
BuyMaintains
$228.00 $237.00
Andrew Fein
HC Wainwright
BuyMaintains
$228.00 $237.00
Ami Fadia
Needham
BuyReiterates
$255.00 $256.00
Michael Yee
UBS
BuyMaintains
$225.00
Michael Yee
UBS
BuyMaintains
$225.00
Eric Schmidt FCA
Cantor Fitzgerald
BuyInitiates
$206.00
Ami Fadia
Needham
BuyUpgrades
-

Frequently Asked Questions

What is the analyst consensus rating for BIIB?

The analyst consensus rating for BIIB is "Buy" based on 34 analyst recommendations.

What is the average price target for BIIB?

The average 12-month price target for BIIB is $229.08, representing an upside of 6.3% from the current price of $215.43.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.